This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Silverman, J. M. Articles by Heyman, A. Search for Related Content PubMed PubMed Citation Articles by Silverman, J. M. Articles by Heyman, A.

NEUROLOGY 1994;44:1253
© 1994 American Academy of Neurology

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Part VI. Family history assessment: A multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls J. M. Silverman, PhD, K. Raiford, MSW, S. Edland, MA, G. Fillenbaum, PhD, J. C. Morris, MD, C. M. Clark, MD, W. Kukull, PhD and A. Heyman, MD

Mt. Sinai School of Medicine (Dr. Silverman), New York, NY; Duke University Medical Center (Drs. Fillenbaum and Heyman and K. Raiford), Durham, NC; the University of Washington (Dr. Kukull and S. Edland), Seattle, WA; Washington University (Dr. Morris), St. Louis, MO; and the University of Pennsylvania (Dr. Clark), Philadelphia, PA.

Although familial factors in Alzheimer's disease (AD) are well established, uniform family-history assessment in genetic and epidemiologic studies of AD is needed to reconcile the divergent estimates of the cumulative risk of this illness among relatives of AD probands. To answer the need, the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) has developed a standardized Family History Assessment of AD to identify the presence of AD, Parkinson's disease (PD), and Down's syndrome (DS) in family members. This paper describes the use of this new assessment instrument in 118 patients with AD (estimated mean age at onset [± SD] = 64.5 ± 7.7 years) and their nondemented spouses who were enrolled in 11 different CERAD sites in the U.S. The first-degree relatives of the probands with AD had a significantly greater cumulative risk (p < 0.005) of AD or primary progressive dementia (24.8%) than did the relatives of spouse controls (15.2%). Furthermore, the cumulative risk for this disorder among female relatives of probands was significantly greater than that among male relatives. There were no differences between the families of probands and controls for the numbers of affected first-degree relatives with PD or DS. This is the first reported multicenter family-history study of AD, and it supports earlier reports of familial factors in AD and indicates a higher risk to female relatives of AD probands. The CERAD Family History Assessment instrument may be useful for further multicenter and epidemiologic studies designed to delineate familial factors associated with AD.

Address correspondence and reprint requests to Dr. J.M. Silverman, Psychiatry Service-116A, Bronx VA Medical Center, 130 W. Kingsbridge Road, Bronx, NY 10468. Address requests for the CERAD Family History Assessment to Dr. A. Heyman, Duke University Medical Center, P.O. Box 3203, Durham, NC 27710.

Received October 10, 1993. Accepted in final form December 30, 1993.

This article has been cited by other articles:

				J. M. Silverman, G. Ciresi, C. J. Smith, D. B. Marin, and M. Schnaider-Beeri Variability of Familial Risk of Alzheimer Disease Across the Late Life Span Arch Gen Psychiatry, May 1, 2005; 62(5): 565 - 573. [Abstract] [Full Text] [PDF]

				G. Levy, E. D. Louis, H. Mejia-Santana, L. Cote, H. Andrews, J. Harris, C. Waters, B. Ford, S. Frucht, S. Fahn, et al. Lack of Familial Aggregation of Parkinson Disease and Alzheimer Disease Arch Neurol, July 1, 2004; 61(7): 1033 - 1039. [Abstract] [Full Text] [PDF]

				G. Devi, J. Williamson, F. Massoud, K. Anderson, Y. Stern, D. P. Devanand, and R. Mayeux A Comparison of Family History of Psychiatric Disorders Among Patients With Early- and Late-Onset Alzheimer's Disease J Neuropsychiatry Clin Neurosci, February 1, 2004; 16(1): 57 - 62. [Abstract] [Full Text] [PDF]

				J. M. Silverman, C. J. Smith, D. B. Marin, R. C. Mohs, and C. B. Propper Familial Patterns of Risk in Very Late-Onset Alzheimer Disease Arch Gen Psychiatry, February 1, 2003; 60(2): 190 - 197. [Abstract] [Full Text] [PDF]

				R. Heun, A. Papassotiropoulos, F. Jessen, W. Maier, and J. C. S. Breitner A Family Study of Alzheimer Disease and Early- and Late-Onset Depression in Elderly Patients Arch Gen Psychiatry, February 1, 2001; 58(2): 190 - 196. [Abstract] [Full Text] [PDF]

				G. Devi, R. Ottman, M.-X. Tang, K. Marder, Y. Stern, and R. Mayeux Familial Aggregation of Alzheimer Disease Among Whites, African Americans, and Caribbean Hispanics in Northern Manhattan Arch Neurol, January 1, 2000; 57(1): 72 - 77. [Abstract] [Full Text] [PDF]

				K. Marder, M.-X. Tang, B. Alfaro, H. Mejia, L. Cote, E. Louis, Y. Stern, and R. Mayeux Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia Neurology, March 1, 1999; 52(4): 719 - 719. [Abstract] [Full Text]

				R. E. Davis, S. Miller, C. Herrnstadt, S. S. Ghosh, E. Fahy, L. A. Shinobu, D. Galasko, L. J. Thal, M. F. Beal, N. Howell, et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease PNAS, April 29, 1997; 94(9): 4526 - 4531. [Abstract] [Full Text] [PDF]